Unknown

Dataset Information

0

Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora.


ABSTRACT: Isepamicin is a weakly toxic but highly active aminoglycoside antibiotic derivative of gentamicin B. Gentamicin B is a naturally occurring minor component isolated from Micromonospora echinospora. 2'-NH2-containing gentamicin C complex is a dominant compound produced by wild-type M. echinospora; by contrast, 2'-OH-containing gentamicin B is produced as a minor component. However, the biosynthetic pathway of gentamicin B remains unclear. Considering that gentamicin B shares a unique C2' hydroxyl group with kanamycin A, we aimed to design a new biosynthetic pathway of gentamicin B by combining twelve steps of gentamicin biosynthesis and two steps of kanamycin biosynthesis.We blocked the biosynthetic pathway of byproducts and generated a strain overproducing JI-20A, which was used as a precursor of gentamicin B biosynthesis, by disrupting genK and genP. The amount of JI-20A produced in M. echinospora ?K?P reached 911 ?g/ml, which was 14-fold higher than that of M. echinospora ?P. The enzymes KanJ and KanK necessary to convert 2'-NH2 into 2'-OH from the kanamycin biosynthetic pathway were heterologously expressed in M. echinospora ?K?P to transform JI-20A into gentamicin B. The strain with kanJK under PermE* could produce 80 ?g/ml of gentamicin B, which was tenfold higher than that of the wild-type strain. To enhance gentamicin B production, we employed different promoters and gene integration combinations. When a PhrdB promoter was used and kanJ and kanK were integrated in the genome through gene replacement, gentamicin B was generated as the major product with a maximum yield of 880 ?g/ml.We constructed a new biosynthetic pathway of high-level gentamicin B production; in this pathway, most byproducts were removed. This method also provided novel insights into the biosynthesis of secondary metabolites via the combinatorial biosynthesis.

SUBMITTER: Ni X 

PROVIDER: S-EPMC4700567 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora.

Ni Xianpu X   Sun Zhenpeng Z   Gu Yawen Y   Cui Hao H   Xia Huanzhang H  

Microbial cell factories 20160105


<h4>Background</h4>Isepamicin is a weakly toxic but highly active aminoglycoside antibiotic derivative of gentamicin B. Gentamicin B is a naturally occurring minor component isolated from Micromonospora echinospora. 2'-NH2-containing gentamicin C complex is a dominant compound produced by wild-type M. echinospora; by contrast, 2'-OH-containing gentamicin B is produced as a minor component. However, the biosynthetic pathway of gentamicin B remains unclear. Considering that gentamicin B shares a u  ...[more]

Similar Datasets

| S-EPMC6963548 | biostudies-literature
| S-EPMC5591436 | biostudies-literature
| S-EPMC4355466 | biostudies-literature
| S-EPMC6713920 | biostudies-literature
| PRJEB24738 | ENA
| S-EPMC5712208 | biostudies-literature
| S-EPMC7247824 | biostudies-literature
| S-EPMC9077841 | biostudies-literature
| S-EPMC7414004 | biostudies-literature
| S-EPMC10017450 | biostudies-literature